Bachem Holding AG (BANB):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Bachem Holding AG (BANB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9769
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Bachem Holding AG (Bachem) is a technology-based biochemical company which develops and manufactures peptides and complex organic molecules including active pharmaceutical ingredients and biochemicals for research purposes. Bachem offers its products and services to the pharmaceutical and biotechnology industries. Bachem’s research products include biologically active peptides, amino acid derivatives, biochemicals and immunology products. It also provides active pharmaceutical ingredients and custom synthesis. These products and services include peptides indicated for the treatment of various conditions such as central nervous system disorders, metabolic disorders, cancer and infectious diseases, among others; research ingredients; new chemical entities; and generics. The company operates production facilities in the US and Europe. Bachem is headquartered in Bubendorf, Switzerland.

Bachem Holding AG (BANB) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Bachem Holding AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Bachem Holding AG, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Magenta Therapeutics Enters into Development and Manufacturing Agreement with Bachem Americas 10
Cyxone Enters into Agreement with Bachem 11
Bachem and Dottikon Enter into Agreement 12
Bachem Enters into Co-Promotion Agreement with Glytech 13
Bachem Expands Co-Marketing Agreement with ILS 14
Acquisition 15
Bachem Americas Acquires American Peptide Company 15
Bachem Holding AG – Key Competitors 16
Bachem Holding AG – Key Employees 17
Bachem Holding AG – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Strategy And Business Planning 19
Jul 20, 2018: Bachem: Footprint in Asia 19
Financial Announcements 20
Aug 24, 2018: Bachem-first half of 2018: further rise in the net profit 20
Corporate Communications 21
Oct 26, 2018: Thomas Meier to become new COO of Bachem Group 21
Other Significant Developments 22
Mar 16, 2018: Bachem: Fiscal year 2017 – Continued increase in sales, profitability and earnings 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Bachem Holding AG, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Bachem Holding AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Bachem Holding AG, Deals By Therapy Area, 2012 to YTD 2018 8
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Magenta Therapeutics Enters into Development and Manufacturing Agreement with Bachem Americas 10
Cyxone Enters into Agreement with Bachem 11
Bachem and Dottikon Enter into Agreement 12
Bachem Enters into Co-Promotion Agreement with Glytech 13
Bachem Expands Co-Marketing Agreement with ILS 14
Bachem Americas Acquires American Peptide Company 15
Bachem Holding AG, Key Competitors 16
Bachem Holding AG, Key Employees 17
Bachem Holding AG, Subsidiaries 18

List of Figures
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Bachem Holding AG (BANB):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hovnanian Enterprises Inc:企業の戦略・SWOT・財務分析
    Hovnanian Enterprises Inc - Strategy, SWOT and Corporate Finance Report Summary Hovnanian Enterprises Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Ramsay Health Care Limited:企業の戦略・SWOT・財務分析
    Ramsay Health Care Limited - Strategy, SWOT and Corporate Finance Report Summary Ramsay Health Care Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Impellam Group plc (IPEL):企業の財務・戦略的SWOT分析
    Impellam Group plc (IPEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • SI-Bone Inc:医療機器:M&Aディール及び事業提携情報
    Summary SI-Bone Inc (SI-BONE) is a medical device company that develops, manufactures and distributes diagnosing and treating patients with SI joint disorders products and tools. The company offers medical devices for patients with low back issues, degenerative sacroiliitis, and SI joint disruptions …
  • Slavneft-Yaroslavnefteorgsintez (JNOS):企業の財務・戦略的SWOT分析
    Summary Slavneft-Yaroslavnefteorgsintez (Slavneft-YANOS), a subsidiary of Slavneft, is an oil and gas company that offers refined petroleum products. The company offers products such as bitumen, motor gasoline, diesel fuel, jet fuel, motor oil, transmission oil, turbine oil, compressor oil, industri …
  • Gran Tierra Energy Inc. (GTE)-石油・ガス分野:企業M&A・提携分析
    Summary Gran Tierra Energy Inc. (Gran Tierra) is an independent energy company. It acquires, explores, and develops oil and gas fields. The company produces crude oil, natural gas, and oil equivalent resources from its fields. Gran Tierra has onshore oil and gas properties in Colombia; and also owns …
  • Berner Oberland-Bahnen AG:企業の戦略・SWOT・財務情報
    Berner Oberland-Bahnen AG - Strategy, SWOT and Corporate Finance Report Summary Berner Oberland-Bahnen AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Duke Energy Indiana LLC:企業の戦略的SWOT分析
    Duke Energy Indiana LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Kumiai Chemical Industry Co Ltd (4996):企業の財務・戦略的SWOT分析
    Summary Kumiai Chemical Industry Co Ltd (Kumiai Chemical) operates as a chemical company that develops, manufactures and markets agricultural chemicals, fine chemicals, and curing agents. The company's agricultural chemicals include bactericides, herbicides, fungicides, acaricides, microbial pestici …
  • Sungrow Power Supply Co Ltd (300274):企業の財務・戦略的SWOT分析
    Summary Sungrow Power Supply Co Ltd (Sungrow) is a renewable energy company that manufactures power supply equipment for solar PV (photovoltaic) and wind power projects. The company's products include PV inverters, floating systems, storage systems and accessories. It offers services such as constru …
  • GlaxoSmithKline Plc (GSK):企業の財務・戦略的SWOT分析
    GlaxoSmithKline Plc (GSK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • FuelCell Energy Inc (FCEL):電力:M&Aディール及び事業提携情報
    Summary FuelCell Energy Inc (FuelCell Energy) is an integrated fuel cell company that designs, manufactures, installs, operates, and services stationary fuel cell power plants for distributed power generation. The company offers proprietary fuel cell products based on carbonate fuel cell technology. …
  • Xactware Solutions Inc:企業の戦略的SWOT分析
    Xactware Solutions Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Elekeiroz SA (ELEK3):企業の財務・戦略的SWOT分析
    Elekeiroz SA (ELEK3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Mitsubishi Tanabe Pharma Corporation:企業の戦略・SWOT・財務情報
    Mitsubishi Tanabe Pharma Corporation - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi Tanabe Pharma Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Sisaf Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Sisaf Ltd (Sisaf) is a drug delivery company which designs and develops topical delivery systems for cosmetic, medical, and skin care applications. The company manufactures and markets products and drug delivery solutions using ProSilic, a nano-silicon technology platform. It offers ProSilli …
  • TrueBlue Inc (TBI):企業の財務・戦略的SWOT分析
    Summary TrueBlue Inc (TrueBlue) is a talent solution company that provides filling individual positions on demand, staffing entire facilities and managing outsourced recruiting processes and staffing vendor programs. The company business division includes People Ready, Workforce Management and Peopl …
  • Argos Therapeutics Inc (ARGS):製薬・医療:M&Aディール及び事業提携情報
    Summary Argos Therapeutics Inc (Argos) is a biopharmaceutical company that develops and commercializes immunotherapies for the treatment of infectious diseases and cancer. The company develops a pipeline of products based on its proprietary Arcelis technology platform. Its Arcelis-based immunotherap …
  • Brenntag Canada Inc:企業の戦略的SWOT分析
    Brenntag Canada Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Big Rivers Electric Corporation:発電所・企業SWOT分析
    Big Rivers Electric Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on k …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆